Log In
Print
BCIQ
Print
Print this Print this
 

AEZS-136

  Manage Alerts
Collapse Summary General Information
Company Aeterna Zentaris Inc.
DescriptionDual MAP kinase 3 (MAPK3; ERK-1)/MAP kinase 1 (MAPK1; ERK-2) and phosphoinositide 3-kinase (PI3K) inhibitor
Molecular Target MAP kinase 3 (MAPK3) (ERK-1) ; Phosphoinositide 3-kinase (PI3K)
Mechanism of ActionMAP kinase (p38) inhibitor; Phosphoinositide 3-kinase (PI3K) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today